Teligent Announces $140m Operating Loss As Plant Woes Continue
Sales Drop By A Third After Challenging 12 Months
Executive Summary
Struggling Teligent underlined the importance of lifting the FDA Warning Letter against its key manufacturing facility in Buena, New Jersey, as its impact slammed the company’s operations last year.
You may also be interested in...
Who’s Hired? Teligent And Centrient Get New CEOs
Teligent CEO Jason Grenfell-Gardner has stepped down with immediate effect, while Centrient CEO Karl Rotthier is preparing to leave the role in March. Both firms have announced details of their replacements. Meanwhile, Stada has appointed a new chief financial officer.
Teligent Slammed By FDA Warning Letter
Rather than blame employees for ignoring 397 product complaints, Teligent should have fixed complaint handling system, US FDA warning letter says.
Rosemont Celebrates One Year Of Independence With 49% Growth
A year on from being spun-out of Perrigo and acquired by private equity, liquid generics specialist Rosemont Pharmaceuticals has revealed new details of the UK-based firm’s operations.